Press release
Brain Metastases Treatment Drugs market: Players tapping Emerging Markets | Bayer AG, Pfizer Inc., Eli Lilly & Company
The Brain Metastases Treatment Drugs global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key factors. Readers can enhance their knowledge on the trading strategies, recent developments, current and future progress of the key players in the Brain Metastases Treatment Drugs global market.
The report includes an in-depth study of the global market segment Brain Metastases Treatment Drugs, where segments and sub-segments are analyzed in quite detail. This research will help players focus on high growth segments and modify their business strategy, if needed. The Brain Metastases Treatment Drugs global market is segmented based on type, application and geography. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, China, Europe, India , US, UK and MEA. Our researchers and analysts use reliable primary and secondary sources for research and data.
Major Players : Bayer AG
Pfizer Inc.
Eli Lilly & Company
Novartis AG
Sanofi
F. Hoffmann-La Roche Ltd.
AstraZeneca
GlaxoSmithKline
Merck & Co., Inc.
AngioChem Inc
Mayo Clinic
Request a sample of the report at : https://www.qyresearch.com/sample-form/form/4962922/Global-Brain-Metastases-Treatment-Drugs-Market-Insights-Forecast-to-2028
Global Brain Metastases Treatment Drugs Market Types: Anticonvulsants
Corticosteroids
Chemotherapy Drugs
Others
Global Brain Metastases Treatment Drugs Market Applications: Cancer Hospitals
Cancer Research Centers
Clinics
Study Coverage: This section includes brief information about key products sold in the global Brain Metastases Treatment Drugs market followed by an overview of important segments and manufacturers covered in the report. It also gives highlights of market size growth rates of different type and application segments. Furthermore, it includes information about study objectives and years considered for the complete research study.
Executive Summary: Here, the report focuses on key trends of various products and other markets. It also shares analysis of the competitive landscape, where prominent players and market concentration ratio are shed light upon. Prominent players are studied on the basis of their date of market entry, products, manufacturing base distribution, and headquarters.
Market Size by Manufacturer: In this part of the report, expansion plans, mergers and acquisitions, and price, revenue, and production by manufacturer are analyzed. This section also provides revenue and production shares by manufacturer.
Production by Region: Apart from global production and revenue shares by region, the authors have shared critical information about regional production in different geographical markets. Each regional market is analyzed taking into account vital factors, viz. import and export, key players, and revenue, besides production.
Consumption by Region: The report concentrates on global and regional consumption here. It provides figures related to global consumption by region such as consumption market share. All of the regional markets studied are assessed on the basis of consumption by country and application followed by analysis of country-level markets.
Market Size by Type: It includes analysis of price, revenue, and production by type.
Market Size by Application: It gives an overview of market size analysis by application followed by analysis of consumption market share, consumption, and breakdown data by application.
Key Industry Players: Leading players of the industry are profiled here on the basis of economic activity and plans, SWOT analysis, products, revenue, production, and other company details.
Entry Strategy for Key Countries: Entry strategies for all of the country-level markets studied in the report are provided here.
Production Forecasts: Apart from global production and revenue forecasts, this section provides production and revenue forecasts by region. It also includes forecast of key producers, where important regions and countries are taken into consideration, followed by forecast by type.
Consumption Forecast: It includes global consumption forecast by application and region. In addition, it provides consumption forecast for all regional markets studied in the report.
Opportunities and Challenges, Threats, and Affecting Factors: It includes Porter's Five Forces analysis, market challenges, opportunities, and other market dynamics.
Key Findings of the Study: These give a clear picture of the current and future status of the global Brain Metastases Treatment Drugs market.
Request for customization in Report: https://www.qyresearch.com/customize-request/form/4962922/Global-Brain-Metastases-Treatment-Drugs-Market-Insights-Forecast-to-2028
Table of Contents:
1 Study Coverage
1.1 Brain Metastases Treatment Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Brain Metastases Treatment Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anticonvulsants
1.2.3 Corticosteroids
1.2.4 Chemotherapy Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Brain Metastases Treatment Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer Hospitals
1.3.3 Cancer Research Centers
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Brain Metastases Treatment Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Brain Metastases Treatment Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Brain Metastases Treatment Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Brain Metastases Treatment Drugs Sales by Region
2.4.1 Global Brain Metastases Treatment Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Brain Metastases Treatment Drugs by Region (2023-2028)
2.5 Global Brain Metastases Treatment Drugs Revenue by Region
2.5.1 Global Brain Metastases Treatment Drugs Revenue by Region (2017-2022)
2.5.2 Global Brain Metastases Treatment Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Brain Metastases Treatment Drugs Sales by Manufacturers
3.1.1 Global Top Brain Metastases Treatment Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Brain Metastases Treatment Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Brain Metastases Treatment Drugs in 2021
3.2 Global Brain Metastases Treatment Drugs Revenue by Manufacturers
3.2.1 Global Brain Metastases Treatment Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Brain Metastases Treatment Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Brain Metastases Treatment Drugs Revenue in 2021
3.3 Global Brain Metastases Treatment Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Brain Metastases Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Brain Metastases Treatment Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Brain Metastases Treatment Drugs Sales by Type
4.1.1 Global Brain Metastases Treatment Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Brain Metastases Treatment Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Brain Metastases Treatment Drugs Sales Market Share by Type (2017-2028)
4.2 Global Brain Metastases Treatment Drugs Revenue by Type
4.2.1 Global Brain Metastases Treatment Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Brain Metastases Treatment Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Brain Metastases Treatment Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Brain Metastases Treatment Drugs Price by Type
4.3.1 Global Brain Metastases Treatment Drugs Price by Type (2017-2022)
4.3.2 Global Brain Metastases Treatment Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Brain Metastases Treatment Drugs Sales by Application
5.1.1 Global Brain Metastases Treatment Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Brain Metastases Treatment Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Brain Metastases Treatment Drugs Sales Market Share by Application (2017-2028)
5.2 Global Brain Metastases Treatment Drugs Revenue by Application
5.2.1 Global Brain Metastases Treatment Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Brain Metastases Treatment Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Brain Metastases Treatment Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Brain Metastases Treatment Drugs Price by Application
5.3.1 Global Brain Metastases Treatment Drugs Price by Application (2017-2022)
5.3.2 Global Brain Metastases Treatment Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Brain Metastases Treatment Drugs Market Size by Type
6.1.1 North America Brain Metastases Treatment Drugs Sales by Type (2017-2028)
6.1.2 North America Brain Metastases Treatment Drugs Revenue by Type (2017-2028)
6.2 North America Brain Metastases Treatment Drugs Market Size by Application
6.2.1 North America Brain Metastases Treatment Drugs Sales by Application (2017-2028)
6.2.2 North America Brain Metastases Treatment Drugs Revenue by Application (2017-2028)
6.3 North America Brain Metastases Treatment Drugs Market Size by Country
6.3.1 North America Brain Metastases Treatment Drugs Sales by Country (2017-2028)
6.3.2 North America Brain Metastases Treatment Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Brain Metastases Treatment Drugs Market Size by Type
7.1.1 Europe Brain Metastases Treatment Drugs Sales by Type (2017-2028)
7.1.2 Europe Brain Metastases Treatment Drugs Revenue by Type (2017-2028)
7.2 Europe Brain Metastases Treatment Drugs Market Size by Application
7.2.1 Europe Brain Metastases Treatment Drugs Sales by Application (2017-2028)
7.2.2 Europe Brain Metastases Treatment Drugs Revenue by Application (2017-2028)
7.3 Europe Brain Metastases Treatment Drugs Market Size by Country
7.3.1 Europe Brain Metastases Treatment Drugs Sales by Country (2017-2028)
7.3.2 Europe Brain Metastases Treatment Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Brain Metastases Treatment Drugs Market Size by Type
8.1.1 Asia Pacific Brain Metastases Treatment Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Brain Metastases Treatment Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Brain Metastases Treatment Drugs Market Size by Application
8.2.1 Asia Pacific Brain Metastases Treatment Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Brain Metastases Treatment Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Brain Metastases Treatment Drugs Market Size by Region
8.3.1 Asia Pacific Brain Metastases Treatment Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Brain Metastases Treatment Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Brain Metastases Treatment Drugs Market Size by Type
9.1.1 Latin America Brain Metastases Treatment Drugs Sales by Type (2017-2028)
9.1.2 Latin America Brain Metastases Treatment Drugs Revenue by Type (2017-2028)
9.2 Latin America Brain Metastases Treatment Drugs Market Size by Application
9.2.1 Latin America Brain Metastases Treatment Drugs Sales by Application (2017-2028)
9.2.2 Latin America Brain Metastases Treatment Drugs Revenue by Application (2017-2028)
9.3 Latin America Brain Metastases Treatment Drugs Market Size by Country
9.3.1 Latin America Brain Metastases Treatment Drugs Sales by Country (2017-2028)
9.3.2 Latin America Brain Metastases Treatment Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Brain Metastases Treatment Drugs Market Size by Type
10.1.1 Middle East and Africa Brain Metastases Treatment Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Brain Metastases Treatment Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Brain Metastases Treatment Drugs Market Size by Application
10.2.1 Middle East and Africa Brain Metastases Treatment Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Brain Metastases Treatment Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Brain Metastases Treatment Drugs Market Size by Country
10.3.1 Middle East and Africa Brain Metastases Treatment Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Brain Metastases Treatment Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Overview
11.1.3 Bayer AG Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer AG Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer AG Recent Developments
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Corporation Information
11.2.2 Pfizer Inc. Overview
11.2.3 Pfizer Inc. Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Inc. Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Inc. Recent Developments
11.3 Eli Lilly & Company
11.3.1 Eli Lilly & Company Corporation Information
11.3.2 Eli Lilly & Company Overview
11.3.3 Eli Lilly & Company Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly & Company Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly & Company Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Corporation Information
11.4.2 Novartis AG Overview
11.4.3 Novartis AG Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis AG Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis AG Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 F. Hoffmann-La Roche Ltd.
11.6.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.6.2 F. Hoffmann-La Roche Ltd. Overview
11.6.3 F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 F. Hoffmann-La Roche Ltd. Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Corporation Information
11.7.2 AstraZeneca Overview
11.7.3 AstraZeneca Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 AstraZeneca Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AstraZeneca Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GlaxoSmithKline Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline Recent Developments
11.9 Merck & Co., Inc.
11.9.1 Merck & Co., Inc. Corporation Information
11.9.2 Merck & Co., Inc. Overview
11.9.3 Merck & Co., Inc. Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merck & Co., Inc. Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck & Co., Inc. Recent Developments
11.10 AngioChem Inc
11.10.1 AngioChem Inc Corporation Information
11.10.2 AngioChem Inc Overview
11.10.3 AngioChem Inc Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AngioChem Inc Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AngioChem Inc Recent Developments
11.11 Mayo Clinic
11.11.1 Mayo Clinic Corporation Information
11.11.2 Mayo Clinic Overview
11.11.3 Mayo Clinic Brain Metastases Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Mayo Clinic Brain Metastases Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Mayo Clinic Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Brain Metastases Treatment Drugs Industry Chain Analysis
12.2 Brain Metastases Treatment Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Brain Metastases Treatment Drugs Production Mode & Process
12.4 Brain Metastases Treatment Drugs Sales and Marketing
12.4.1 Brain Metastases Treatment Drugs Sales Channels
12.4.2 Brain Metastases Treatment Drugs Distributors
12.5 Brain Metastases Treatment Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Brain Metastases Treatment Drugs Industry Trends
13.2 Brain Metastases Treatment Drugs Market Drivers
13.3 Brain Metastases Treatment Drugs Market Challenges
13.4 Brain Metastases Treatment Drugs Market Restraints
14 Key Findings in The Global Brain Metastases Treatment Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Contact Us:
QY Research, INC.
17890 Castleton, Suite 369,
Los Angeles, CA - 91748
USA: +1 626 539 9760
India: +91 9766 478 224
Emails - enquiry@qyresearch.com
Web - www.qyresearch.com
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.
Contact US:
QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
+1 626 539 9760 / +91 8669986909
hitesh@qyresearch.com / enquiry@qyresearch.com"
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Brain Metastases Treatment Drugs market: Players tapping Emerging Markets | Bayer AG, Pfizer Inc., Eli Lilly & Company here
News-ID: 2731988 • Views: …
More Releases from QYResearch Inc.
Perovskite Solar Cells Module Market Size, Top Players and Forecast Analysis Com …
LOS ANGELES, United States: The report named, "Global Perovskite Solar Cells Module Market Research Report 2024" has been added to the archive of market research studies by QY Research. The industry experts and researchers have offered reliable and precise analysis of the global Perovskite Solar Cells Module market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, and growth opportunities. This report will surely act as…
Polyimide (PI) Market Size Historical Growth, Analysis, Opportunities and Foreca …
LOS ANGELES, United States: The report named, "Global Polyimide (PI) Market Research Report 2024" has been added to the archive of market research studies by QY Research. The industry experts and researchers have offered reliable and precise analysis of the global Polyimide (PI) market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, and growth opportunities. This report will surely act as a handy instrument for…
Pneumatic Tools Market Poised for Robust Growth in 2024: Emerging Trends and Opp …
LOS ANGELES, United States: The report named, "Global Pneumatic Tools Market Research Report 2024" has been added to the archive of market research studies by QY Research. The industry experts and researchers have offered reliable and precise analysis of the global Pneumatic Tools market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, and growth opportunities. This report will surely act as a handy instrument for…
Cork Flooring Market Outlook: Key Players, Product Innovations, and Market Expan …
LOS ANGELES, United States: The report named, "Global Cork Flooring Market Research Report 2024" has been added to the archive of market research studies by QY Research. The industry experts and researchers have offered reliable and precise analysis of the global Cork Flooring market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, and growth opportunities. This report will surely act as a handy instrument for…
More Releases for Drugs
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database.
In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),…
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests.
On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.…
